Active Shortage

GLN-GABAPENTIN

GLENMARK PHARMACEUTICALS CANADA INC.

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of GLN-GABAPENTIN in Canada?

Yes. GLN-GABAPENTIN 600MG has an active shortage reported to Health Canada (last updated October 27, 2026).

When will GLN-GABAPENTIN be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusActive Shortage

Same-ingredient products on file6 products · 0 same form & route

Affected strength600MG

Report last updated2026-10-27

Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

PMS-GABAPENTIN

PHARMASCIENCE INC

100MG · DIN 02243446

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

GABAPENTIN

SIVEM PHARMACEUTICALS ULC

100MG · DIN 02246314

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

RIVA-GABAPENTIN

LABORATOIRE RIVA INC.

400MG · DIN 02251183

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

AURO-GABAPENTIN

AURO PHARMA INC

100MG · DIN 02321203

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

PRO-GABAPENTIN

PRO DOC LIMITEE

100MG · DIN 02310449

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

AURO-GABAPENTIN TABLETS

AURO PHARMA INC

800MG · DIN 02428342

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02410990

Strength

600MG

Dosage Form

TABLET TABLET (IMMEDIATE RELEASE)

Route

ORAL

Active Ingredient

GABAPENTIN

Tier

Unrated

Last Updated

2026-10-27

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Other Products from GLENMARK PHARMACEUTICALS CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS

DIN 02466783

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP

DIN 02462060

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21

DIN 02421437

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28

DIN 02421445

30MG · DIN 02518910

750MG · DIN 02528495

20MG · DIN 02544369

GLN-DAPAGLIFLOZIN

5MG · DIN 02519852

GLN-DAPAGLIFLOZIN

10MG · DIN 02519860

800MG · DIN 02411008

40MG · DIN 02469820

20MG · DIN 02469812